ORLIFIT 60 MG CAPSULE Capsule

About ORLIFIT 60 MG CAPSULE 120 mg

The capsule ORLIFIT 60 MG CAPSULE contains Orlistat and is made by Opsonin Pharma Limited. It is not a weight-loss medicine for everyone, and your doctor will decide whether it is appropriate for you after assessing your body weight, health status and other conditions.

There are 5 brands of Orlistat listed in Bangladesh. 1 of them has a lower unit price than ORLIFIT 60 MG CAPSULE. The lowest listed price is Adiponil 120 mg Capsule at ৳ 40.00 per unit.

What is ORLIFIT 60 MG CAPSULE 120 mg?

ORLIFIT 60 MG CAPSULE 120 mg capsule is a medicine made by Opsonin Pharma Limited. It acts in the stomach and upper small intestine by blocking lipase enzymes, so some dietary fat is not broken down and absorbed. It is meant to be used alongside a mildly hypocaloric diet. The doctor decides the dose and course.

Uses of ORLIFIT 60 MG CAPSULE

It is not a weight-loss medicine for everyone, and your doctor will decide whether it is appropriate for you after assessing your body weight, health status and other conditions. ORLIFIT 60 MG CAPSULE is used for weight management in adults, together with a mildly calorie-reduced diet. It is a weight-management medicine, not a general vitamin or supplement. The doctor decides the dose and course.

How to use ORLIFIT 60 MG CAPSULE

Take ORLIFIT 60 MG CAPSULE as your doctor instructs. Swallow the capsule whole with water. ORLIFIT 60 MG CAPSULE is taken by mouth. Do not attempt to use it yourself. Follow the diet plan your doctor gives alongside it. Do not change the dose or stop early without asking your doctor.

Side effects of ORLIFIT 60 MG CAPSULE

Most unwanted effects of Orlistat are digestive. Less often, some people may have influenza-like symptoms, anxiety, headache, fatigue, or signs of hypersensitivity such as itching, rash, hives, swelling or a severe allergic reaction. Common ones include oily spotting from the rectum, flatulence, fecal urgency, oily or fatty stool and abdominal discomfort. Tell your doctor if any side effect bothers you or does not go away. Tell your doctor if side effects bother you or do not settle.

Safety and precautions

Before prescribing, the doctor should rule out organic causes of obesity such as hypothyroidism. Before starting ORLIFIT 60 MG CAPSULE, your doctor should rule out medical causes of obesity such as an underactive thyroid. Do not use ORLIFIT 60 MG CAPSULE if you have chronic malabsorption syndrome, cholestasis, or an allergy to Orlistat or any ingredient of the capsule. Tell your doctor about all the other medicines you take.

Frequently asked questions

What does ORLIFIT 60 MG CAPSULE treat?

It is not a weight-loss medicine for everyone, and your doctor will decide whether it is appropriate for you after assessing your body weight, health status and other conditions. ORLIFIT 60 MG CAPSULE is used for weight management in adults, together with a mildly calorie-reduced diet.

How is ORLIFIT 60 MG CAPSULE used?

Take ORLIFIT 60 MG CAPSULE as your doctor instructs. Swallow the capsule whole with water.

What are the side effects of ORLIFIT 60 MG CAPSULE?

Most unwanted effects of Orlistat are digestive. Less often, some people may have influenza-like symptoms, anxiety, headache, fatigue, or signs of hypersensitivity such as itching, rash, hives, swelling or a severe allergic reaction.

Who should be careful with ORLIFIT 60 MG CAPSULE?

Before prescribing, the doctor should rule out organic causes of obesity such as hypothyroidism. Before starting ORLIFIT 60 MG CAPSULE, your doctor should rule out medical causes of obesity such as an underactive thyroid.

Indications

Adults: Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI)>30 kg/m2 and overweight patients (BMI >28 kg/m2 ) with associated risk factors such as type II diabetes, hyperlipidemia ... Read moreAdults: Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI)>30 kg/m2 and overweight patients (BMI >28 kg/m2 ) with associated risk factors such as type II diabetes, hyperlipidemia and hypertension. Treatment with Orlistat should be discontinued after 12 weeks in patients who have not lost at least 5% of their body weight as measured at the start of drug therapy.

Adolescents (12 years & older): Obese adolescents should be treated with Orlistat only if an adequate reduction of body weight cannot be achieved by means of diet & increased physical activity. Treatment with orlistat should be considered in particular if complications of obesity are present.

Pharmacology

Orlistat is a potent, specific and long-acting lipase inhibitor. It exerts its therapeutic activity in the lumen of the stomach and upper small intestine by forming a covalent bond with the active serine site of gastric and pancreatic lipases. The inactivated enzyme is thus rendered unable to hydrolyze dietary fats in the form of triglycerides into absorbable free fatty acids and monoglycerides. As undigested triglycerides can not be absorbed, a caloric deficit arises which has a positive effect on weight control. Systemic absorption of orlistat is therefore not needed for the activity. At the recommended therapeutic dose of 120 mg three times a day, orlistat inhibit dietary fat absorption by approximately 30%.

Dosage & Administration

The recommended dose of Orlistat is one 120 mg capsule to be taken immediately before, during or up to one hour after each main meal. If a meal is missed or contains no fat the dose of Orlistat should be omitted. Doses of Orlistat above 120 mg three times daily have not been shown to provide additional benefits. The effect of Orlistat results in an increase in fecal fat 24-48 hours after dosing. Upon discontinuation of therapy, fecal fat content usually returns to pretreatment levels within 48-72 hours.

The safety & efficacy of Orlistat were investigated in clinical studies lasting up to 4 years. The recommended dose of Orlistat for adolescents is as same as adults.

Special dosage instruction: The tolerability and efficacy of Orlistat have not been studied in elderly patients, or patients with hepatic and/ or renal impairments.

Interaction

No interactions with commonly prescribed medications such as alcohol, digoxin, nifedipine, oral contraceptives, phenytoin, pravastatin, warfarin, or metformin, glibenclamide, fibrates, furosemide, captopril, or atenolol have been observed in studies.

Contraindications

Orlistat is contraindicated in patients with chronic malabsorption syndrome, in patients with cholestasis and in patients who are hypersensitive to orlistat or to any of the other ingredients of the capsules.

Side Effects

Common: Undesirable effects of Orlistat are largely gastrointestinal in nature. Common gastrointestinal side effects are oily spotting from the rectum, flatulence, fecal urgency, oily or fatty stool, abdominal discomfort etc.

Rare: Influenza, anxiety. headache, fatigue etc may rarely occur in some patients. Rare cases of hypersensitivity have been reported. Main clinical symptoms are pruritus, exanthema, urticaria, angioedema and anaphylaxis.

Pregnancy & Lactation

Use in pregnancy & lactation: No clinical data are available on pregnancy exposed to Orlistat. As it is not known whether Orlistat is excreted in breast milk. Orlistat should not be used during breastfeeding.

Precautions & Warnings

Organic causes of obesity (e.g. hypothyroidism) should be excluded before prescribing Orlistat. Orlistat and cyclosporine should not be coadministered. Cyclosporine should be taken at least 2 hours before or after Orlistat in patients taking both drugs. Cyclosporine level should be measured and frequently monitored.

In clinical trial, the decrease in body weight with Orlistat therapy was less in type II diabetic patients than in non-diabetic patients. Antidiabetic drug treatment should be closely monitored during Orlistat therapy. Because of the improvement in glycemic control, the dose of oral antidiabetics or of insulin may need to be adjusted.

Patients should be advised to adhere to the dietary recommendations. The probability of occurrence of gastrointestinal side effects may increase when Orlistat is taken with a fatty meal. The daily intake of fat should be distributed between three main meals. Patients should be strongly encouraged to take a multivitamin supplement that contains fat soluble vitamins to ensure adequate nutrition because orlistat has been shown to reduce the absorption of some fat soluble vitamins & beta-carotene. In addition, the levels of vitamin D & beta carotene may be low in obese patients compared with non-obese patients.

Overdose Effects

Single doses of 800 mg Orlistat and multiple doses of up to 400 mg three times a day for 15 days have been studied in normal weight and obese subjects without significant adverse findings.

Storage Conditions

Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.

Alternative brands of Orlistat

Other brands with the same generic name, cheapest first.

Adiponil Capsule

120 mg

Orlistat

Incepta Pharmaceuticals Ltd.

৳ 39.2 ৳ 40.00 2% off per unit

Ornical Capsule

120 mg

Orlistat

Advanced Chemical Industries PLC

৳ 53.9 ৳ 55.00 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.